Accel-Rx Growth Platform (2021) -

Amount:

$500,000

Type of Program:

Investment

Description:

Accel-Rx Growth Platform is a collaborative partnership-based program focusing on Capital, Connections, and Acumen to help companies prepare for the next stage. Accel-Rx stewards companies through the seed stage of development to a level where they can successfully raise a series A or similar type of venture financing.

Comments on Funding:

Funding from Accel-Rx is up to $500,000 per company, which is further matched by third-party investors.

When It Ends:

Ongoing

Deadline:

Rolling deadline

Eligibility:

The applicant must:

Be incorporated in Canada
Have validated a technology for therapeutic, diagnostic, or medical device
Be the company that has ownership or control of the intellectual property
Be valued between $1 - $5 million
Have taken previous external funding less than $2 million

Documentation Needed:

Applicants must:

Make a presentation to Accel-Rx team for initial screening
Submit a pre-proposal if selected
Submit a full proposal if selected
Make a final presentation to Accel-Rx team and Investment Committee

Other Things to Note:

adMare BioInnovations & Accel-Rx Unite to Advance the Canadian Life Sciences Sector

Program Contact:

Accel-RX website

Maurice

Maurice (Moe) Muise learned the ins-and-outs of government while an employee of the Government of Canada in Ottawa for 10 years. His current focus is helping small businesses in Ontario to identify and maximize government grants to grow their business.

Click here to learn more about Moe’s background and how he can help your business.

Reader Interactions

Leave a Reply Cancel reply